Please login or register to print this page.

Clinical Articles, News & Views

Global AF treatment market to peak in 2020

The global market for atrial fibrillation (AF) treatment will more than double in value from $4.6 billion in 2013 to peak sales of $9.4 billion in 2020, before declining to $5.7 billion by 2023 as novel oral anticoagulants (NOACs) become genericised, according to a recent report from research and consulting firm GlobalData.1

The company’s latest report states that NOACs have seen substantial uptake since the launch of dabigatran in 2010, with the drugs accounting for approximately 70% of all AF therapeutics sales in 2013. Dr Haylyn Wong, GlobalData’s Senior Analyst covering Cardiovascular and Metabolic Disorders, says the increased adoption of NOACs will be the primary driver of market growth across the eight major markets, comprising of the US, France, Germany, Italy, Spain, UK, Japan, and Canada, over the forecast period.

Dr Wong explains: “Prior to the approval of the first NOACs…the anticoagulant market for the prevention of stroke in AF patients was dominated by generic vitamin K antagonists, particularly warfarin…However, GlobalData expects that the advances offered by NOACs in terms of improved safety and the lack of a need for routine monitoring will see these treatments taking market share away from warfarin.”

“NOACs are also expected to be used as an alternative to antiplatelet therapy, particularly aspirin use, which has historically been prescribed for AF patients with a low risk of stroke. This is due to revised AF treatment guidelines downgrading the use of aspirin and a lack of evidence for the product’s efficacy in preventing stroke in these patients,” Dr Wong concludes.


1. PharmaPoint: atrial fibrillation – global drug forecast and market analysis to 2023. GlobalData 2015. Available from

Published on: April 29, 2015

Members Area

Log in or Register now.



Subscribe to our RSS feed


Sign up for our regular email newsletters & be the first to know about fresh articles and site updates.


    None Found


  • ArrhythmiaAlliance
  • Stars
  • Anticoagulation Europe
  • Atrial Fibrillation Association

You are not logged in

You need to be a member to print this page.
Sign up for free membership, or log in.

You are not logged in

You need to be a member to download PDF's.
Sign up for free membership, or log in.